Landmark Health Administers Spravato™ for Depression to First WNY Patient

Landmark Health Systems First in Western New York to Administer FDA-approved Spravato™ (Esketamine) for Depression to First Western New York Patient Buffalo, NY – April 24 – Jarod Masci, M.D., Psychiatrist and President of Landmark Health Systems is the first to administer Spravato™(esketamine) nasal spray to a

Read more